Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 402

1.

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.

Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS; TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group.

Pediatr Diabetes. 2009 Apr;10(2):97-104. doi: 10.1111/j.1399-5448.2008.00464.x. Epub 2008 Sep 24.

PMID:
18823409
[PubMed - indexed for MEDLINE]
2.

The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.

Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.

Exp Clin Endocrinol Diabetes. 1999;107(8):496-505.

PMID:
10612480
[PubMed - indexed for MEDLINE]
3.

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.

Diabetologia. 2006 May;49(5):881-90. Epub 2006 Mar 3.

PMID:
16514546
[PubMed - indexed for MEDLINE]
4.

Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators.

Diabetes. 2001 Aug;50(8):1735-40.

PMID:
11473032
[PubMed - indexed for MEDLINE]
Free Article
5.

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.

PMID:
18000175
[PubMed - indexed for MEDLINE]
7.

IA-2 autoantibodies predict impending type I diabetes in siblings of patients.

Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, Vandemeulebroucke E, Truyen I, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2002 Dec;45(12):1658-66. Epub 2002 Nov 12.

PMID:
12488955
[PubMed - indexed for MEDLINE]
8.

Prediabetic markers in children with stress hyperglycemia.

Bhisitkul DM, Vinik AI, Morrow AL, She JX, Shults J, Powers AC, Maclaren NK.

Arch Pediatr Adolesc Med. 1996 Sep;150(9):936-41.

PMID:
8790124
[PubMed - indexed for MEDLINE]
9.

Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.

Truyen I, De Pauw P, Jørgensen PN, Van Schravendijk C, Ubani O, Decochez K, Vandemeulebroucke E, Weets I, Mao R, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2005 Nov;48(11):2322-9. Epub 2005 Oct 7.

PMID:
16211374
[PubMed - indexed for MEDLINE]
10.

Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

Pediatr Diabetes. 2004 Jun;5(2):72-9.

PMID:
15189492
[PubMed - indexed for MEDLINE]
11.

Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives.

Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ; ENDIT Group.

Diabetologia. 2008 Mar;51(3):488-92. doi: 10.1007/s00125-007-0912-9. Epub 2008 Jan 9.

PMID:
18193190
[PubMed - indexed for MEDLINE]
12.

The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.

Gorus FK.

Verh K Acad Geneeskd Belg. 1996;58(5):539-86. Review.

PMID:
9008403
[PubMed - indexed for MEDLINE]
13.

Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study.

LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA; Washingtno State Diabetes Prediction Study.

Diabetes Care. 2002 Mar;25(3):505-11.

PMID:
11874938
[PubMed - indexed for MEDLINE]
14.

Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.

Pediatr Diabetes. 2005 Dec;6(4):184-92.

PMID:
16390386
[PubMed - indexed for MEDLINE]
15.

[Presence of markers predictive of type I pre-diabetes mellitus status in relatives of patients with type I diabetes mellitus].

Rodríguez-Villar C, Conget I, Esmatjes E, Levy I, Calvet J, Figuerola D, Bergua M, Gutiérrez A, Miralles J, Millán M, Peig M, Gomis R.

Med Clin (Barc). 1996 Sep 28;107(10):371-4. Spanish.

PMID:
9036240
[PubMed - indexed for MEDLINE]
16.

Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

Triolo TM, Chase HP, Barker JM; DPT-1 Study Group.

Diabetes Care. 2009 May;32(5):769-73. doi: 10.2337/dc08-1872.

PMID:
19407074
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

Stene LC, Barriga K, Hoffman M, Kean J, Klingensmith G, Norris JM, Erlich HA, Eisenbarth GS, Rewers M.

Pediatr Diabetes. 2006 Oct;7(5):247-53.

PMID:
17054445
[PubMed - indexed for MEDLINE]
18.

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E.

Diabetes Care. 2005 May;28(5):1068-76.

PMID:
15855569
[PubMed - indexed for MEDLINE]
19.

A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants.

Sosenko JM, Mahon J, Rafkin L, Lachin JM, Krause-Steinrauf H, Krischer JP, Cuthbertson D, Palmer JP, Thompson C, Greenbaum CJ, Skyler JS; Diabetes Prevention Trial-Type 1 and TrialNet Study Groups.

Pediatr Diabetes. 2011 Mar;12(2):85-90. doi: 10.1111/j.1399-5448.2010.00662.x.

PMID:
20522170
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes.

Chase HP, Cuthbertson DD, Dolan LM, Kaufman F, Krischer JP, Schatz DA, White NH, Wilson DM, Wolfsdorf J.

J Pediatr. 2001 Feb;138(2):244-9.

PMID:
11174623
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk